RLX Technology Key Executives
This section highlights RLX Technology's key executives, including their titles and compensation details.
Find Contacts at RLX Technology
(Showing 0 of )
RLX Technology Earnings
This section highlights RLX Technology's earnings, including key dates, EPS, earnings reports, and earnings call transcripts.
Next Earnings Date
Last Earnings Results
Earnings Call Transcripts
Transcript | Quarter | Year | Date | Estimated EPS | Actual EPS |
---|---|---|---|---|---|
Read Transcript | Q4 | 2024 | 2025-03-14 | $0.20 | $0.01 |
Read Transcript | Q3 | 2024 | 2024-11-15 | $0.03 | $0.02 |
Read Transcript | Q2 | 2024 | 2024-08-16 | $0.18 | $0.01 |
Read Transcript | Q1 | 2024 | 2024-05-17 | $0.16 | $-0.01 |
Read Transcript | Q4 | 2023 | 2024-03-15 | $0.14 | $0.02 |
Read Transcript | Q3 | 2023 | 2023-11-13 | $0.10 | $0.02 |
Read Transcript | Q2 | 2023 | 2023-08-18 | $0.01 | $0.02 |
Read Transcript | Q1 | 2023 | 2023-05-17 | N/A | N/A |

RLX Technology Inc., together with its subsidiaries, researchers, develops, manufactures, distributes, and sells e-vapor products in the People's Republic of China. It serves RELX branded partner stores and other retail outlets through distributors. RLX Technology Inc. was founded in 2018 and is based in Beijing, China.
$1.89
Stock Price
$2.38B
Market Cap
-
Employees
Beijing, None
Location
Financial Statements
Access annual & quarterly financial statements for RLX Technology, including income statements, balance sheets, and cash flow statements..
Annual Income Statement
Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
---|---|---|---|---|---|
Revenue | $2.44B | $1.24B | $5.33B | $8.52B | $3.82B |
Cost of Revenue | $1.72B | $856.33M | $3.03B | $4.85B | $2.29B |
Gross Profit | $726.52M | $387.71M | $2.31B | $3.67B | $1.53B |
Gross Profit Ratio | 29.72% | 31.17% | 43.23% | 43.10% | 39.99% |
Research and Development Expenses | $88.31M | $172.69M | $317.11M | $179.91M | $299.29M |
General and Administrative Expenses | $515.89M | $498.01M | $576.81M | $672.75M | $771.97M |
Selling and Marketing Expenses | $229.47M | $213.72M | $347.80M | $520.69M | $443.15M |
Selling General and Administrative Expenses | $745.35M | $711.74M | $924.61M | $1.19B | $1.22B |
Other Expenses | $- | $- | $399.64M | $194.21M | $36.52M |
Operating Expenses | $833.66M | $884.42M | $1.24B | $1.37B | $1.51B |
Cost and Expenses | $2.55B | $1.74B | $4.27B | $6.22B | $3.81B |
Interest Income | $- | $627.88M | $180.73M | $3.41M | $52.76M |
Interest Expense | $- | $- | $180.73M | $- | $32.41M |
Depreciation and Amortization | $46.51M | $96.60M | $164.46M | $113.55M | $62.45M |
EBITDA | $-60.63M | $-400.11M | $1.06B | $2.30B | $13.15M |
EBITDA Ratio | -2.48% | -32.16% | 17.38% | 25.87% | -0.19% |
Operating Income | $-107.14M | $-496.71M | $1.06B | $2.30B | $13.15M |
Operating Income Ratio | -4.38% | -39.93% | 19.94% | 26.98% | 0.34% |
Total Other Income Expenses Net | $765.95M | $1.09B | $716.90M | $360.85M | $89.28M |
Income Before Tax | $658.80M | $591.74M | $1.78B | $2.66B | $102.43M |
Income Before Tax Ratio | 26.95% | 47.57% | 33.38% | 31.21% | 2.68% |
Income Tax Expense | $94.46M | $50.76M | $371.58M | $631.43M | $230.53M |
Net Income | $551.84M | $534.33M | $1.44B | $2.02B | $-128.10M |
Net Income Ratio | 22.57% | 42.95% | 27.03% | 23.76% | -3.35% |
EPS | $0.43 | $0.40 | $1.09 | $1.45 | $-0.08 |
EPS Diluted | $0.43 | $0.40 | $1.09 | $1.44 | $-0.08 |
Weighted Average Shares Outstanding | 1.29B | 1.34B | 1.32B | 1.40B | 1.55B |
Weighted Average Shares Outstanding Diluted | 1.29B | 1.34B | 1.33B | 1.41B | 1.55B |
SEC Filing | Source | Source | Source | Source | Source |
Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $736.21M | $679.36M | $558.57M | $470.38M | $521.60M | $327.76M | $378.12M | $188.88M | $340.01M | $1.04B | $2.23B | $1.71B | $1.90B | $1.68B | $2.54B | $2.40B | $1.62B | $1.12B | $712.50M | $368.60M |
Cost of Revenue | $516.30M | $473.38M | $400.71M | $327.61M | $383.85M | $222.06M | $279.59M | $143.15M | $191.74M | $522.45M | $1.26B | $1.06B | $1.14B | $1.02B | $1.39B | $1.29B | $924.32M | $682.62M | $450.07M | $235.15M |
Gross Profit | $219.91M | $205.98M | $157.86M | $142.77M | $137.75M | $105.70M | $98.54M | $45.73M | $148.27M | $521.97M | $977.88M | $657.00M | $765.53M | $655.97M | $1.15B | $1.10B | $694.14M | $437.54M | $262.43M | $133.45M |
Gross Profit Ratio | 29.87% | 30.30% | 28.30% | 30.40% | 26.40% | 32.20% | 26.10% | 24.20% | 43.60% | 50.00% | 43.80% | 38.30% | 40.20% | 39.10% | 45.10% | 46.00% | 42.89% | 39.06% | 36.83% | 36.20% |
Research and Development Expenses | $32.37M | $24.43M | $-40.00K | $31.54M | $21.90M | $30.79M | $43.32M | $76.68M | $129.56M | $45.98M | $117.57M | $24.01M | $17.80M | $-44.61M | $-4.91M | $211.63M | $208.89M | $38.55M | $27.57M | $24.28M |
General and Administrative Expenses | $153.71M | $123.23M | $129.00M | $109.95M | $208.36M | $74.52M | $-41.37M | $256.50M | $394.21M | $-41.75M | $290.75M | $-66.39M | $167.11M | $-253.23M | $46.06M | $712.81M | $447.05M | $254.81M | $36.43M | $33.69M |
Selling and Marketing Expenses | $45.37M | $68.97M | $62.23M | $52.89M | $43.04M | $39.70M | $45.23M | $85.76M | $96.67M | $52.54M | $122.63M | $75.95M | $46.63M | $56.52M | $126.00M | $291.54M | $196.68M | $86.65M | $85.76M | $74.06M |
Selling General and Administrative Expenses | $199.08M | $192.20M | $191.23M | $162.84M | $251.40M | $114.22M | $3.86M | $342.26M | $490.88M | $10.80M | $413.38M | $9.55M | $213.74M | $-196.71M | $172.06M | $1.00B | $643.73M | $341.46M | $122.18M | $107.75M |
Other Expenses | $1 | $- | $- | $- | $31.09M | $33.25M | $21.38M | $129.16M | $150.62M | $16.57M | $115.59M | $116.86M | $37.69M | $150.50M | $9.19M | $-3.17M | $13.06M | $10.51M | $315.00K | $12.64M |
Operating Expenses | $231.45M | $216.64M | $191.19M | $194.38M | $273.30M | $145.00M | $47.17M | $418.95M | $620.44M | $56.78M | $530.95M | $33.56M | $231.53M | $-241.31M | $167.15M | $1.22B | $852.62M | $380.01M | $149.75M | $132.03M |
Cost and Expenses | $747.76M | $690.01M | $591.90M | $521.99M | $657.15M | $367.06M | $326.76M | $562.10M | $812.18M | $579.23M | $1.79B | $1.09B | $1.37B | $779.44M | $1.56B | $2.51B | $1.78B | $1.06B | $599.82M | $367.18M |
Interest Income | $- | $156.66M | $154.21M | $158.86M | $157.93M | $158.26M | $162.89M | $148.80M | $80.17M | $56.24M | $42.72M | $27.15M | $24.30M | $22.63M | $16.07M | $9.41M | $19.30M | $17.08M | $8.84M | $6.17M |
Interest Expense | $- | $- | $- | $- | $- | $- | $- | $- | $54.62M | $56.24M | $42.72M | $27.15M | $- | $- | $- | $- | $32.41M | $5.84M | $- | $1.52M |
Depreciation and Amortization | $11.63M | $- | $- | $- | $11.63M | $20.35M | $20.35M | $20.35M | $20.35M | $11.41M | $11.41M | $11.41M | $11.41M | $5.77M | $5.77M | $5.77M | $14.66M | $5.52M | $788.75K | $788.75K |
EBITDA | $81.50K | $-10.66M | $-33.33M | $-51.61M | $-123.92M | $-18.95M | $51.36M | $-352.87M | $-472.17M | $465.20M | $446.94M | $623.44M | $534.00M | $897.28M | $979.34M | $-106.14M | $-158.48M | $57.53M | $112.68M | $1.42M |
EBITDA Ratio | 0.01% | -1.57% | -8.24% | -13.69% | -61.01% | -18.41% | 8.14% | -208.92% | -146.38% | 40.89% | 18.19% | 34.48% | 26.57% | 51.88% | 37.60% | -5.29% | -10.51% | 4.61% | 15.62% | -0.03% |
Operating Income | $-11.55M | $-10.66M | $-33.33M | $-51.61M | $-135.55M | $-39.30M | $51.36M | $-373.22M | $-472.17M | $465.20M | $446.94M | $623.44M | $534.00M | $897.28M | $979.34M | $-111.91M | $-158.48M | $57.53M | $112.68M | $1.42M |
Operating Income Ratio | -1.57% | -1.57% | -5.97% | -10.97% | -25.99% | -11.99% | 13.58% | -197.60% | -138.87% | 44.54% | 20.01% | 36.36% | 28.04% | 53.51% | 38.54% | -4.67% | -9.79% | 5.14% | 15.81% | 0.39% |
Total Other Income Expenses Net | $165.23M | $210.47M | $189.66M | $200.58M | $371.72M | $212.53M | $204.86M | $299.35M | $230.80M | $110.91M | $198.94M | $176.25M | $89.95M | $200.59M | $49.12M | $21.17M | $32.36M | $27.59M | $10.52M | $18.81M |
Income Before Tax | $153.69M | $199.81M | $156.33M | $148.97M | $236.17M | $173.23M | $256.22M | $-73.88M | $-241.37M | $576.11M | $645.88M | $799.69M | $623.95M | $1.10B | $1.03B | $-90.74M | $-126.12M | $85.12M | $123.19M | $20.24M |
Income Before Tax Ratio | 20.88% | 29.41% | 27.99% | 31.67% | 45.28% | 52.85% | 67.76% | -39.11% | -70.99% | 55.16% | 28.91% | 46.64% | 32.76% | 65.48% | 40.47% | -3.78% | -7.79% | 7.60% | 17.29% | 5.49% |
Income Tax Expense | $26.30M | $30.42M | $21.39M | $16.34M | $16.29M | $534.00K | $51.50M | $-17.57M | $-16.24M | $70.87M | $204.32M | $112.64M | $129.54M | $121.44M | $204.15M | $176.29M | $110.62M | $77.29M | $34.48M | $8.14M |
Net Income | $121.96M | $165.65M | $132.31M | $131.91M | $217.52M | $170.99M | $202.79M | $-56.30M | $-225.12M | $503.36M | $461.06M | $705.28M | $493.52M | $973.91M | $824.30M | $-267.03M | $-236.75M | $7.83M | $88.71M | $12.10M |
Net Income Ratio | 16.57% | 24.38% | 23.69% | 28.04% | 41.70% | 52.17% | 53.63% | -29.81% | -66.21% | 48.19% | 20.64% | 41.14% | 25.92% | 58.08% | 32.44% | -11.13% | -14.63% | 0.70% | 12.45% | 3.28% |
EPS | $0.09 | $0.14 | $0.11 | $0.01 | $0.17 | $0.13 | $0.15 | $-0.04 | $-0.17 | $0.38 | $0.35 | $0.53 | $0.37 | $0.72 | $0.60 | $-0.17 | $-0.15 | $0.01 | $0.06 | $0.01 |
EPS Diluted | $0.09 | $0.13 | $0.10 | $0.01 | $0.16 | $0.13 | $0.15 | $-0.04 | $-0.17 | $0.38 | $0.35 | $0.52 | $0.36 | $0.72 | $0.59 | $-0.17 | $-0.15 | $0.01 | $0.06 | $0.01 |
Weighted Average Shares Outstanding | 1.30B | 1.23B | 1.23B | 1.25B | 1.33B | 1.32B | 1.32B | 1.32B | 1.31B | 1.32B | 1.32B | 1.34B | 1.35B | 1.35B | 1.39B | 1.53B | 1.55B | 1.55B | 1.55B | 1.51B |
Weighted Average Shares Outstanding Diluted | 1.29B | 1.29B | 1.28B | 1.30B | 1.32B | 1.34B | 1.35B | 1.32B | 1.31B | 1.33B | 1.33B | 1.35B | 1.36B | 1.36B | 1.39B | 1.53B | 1.55B | 1.55B | 1.55B | 1.55B |
SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source |
Annual Balance Sheet
Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
---|---|---|---|---|---|
Cash and Cash Equivalents | $5.59B | $2.39B | $1.27B | $5.21B | $1.11B |
Short Term Investments | $2.90B | $5.72B | $9.52B | $7.64B | $1.97B |
Cash and Short Term Investments | $8.49B | $8.11B | $10.79B | $12.85B | $3.08B |
Net Receivables | $429.34M | $164.70M | $59.49M | $25.97M | $54.56M |
Inventory | $142.55M | $144.85M | $130.90M | $589.09M | $329.12M |
Other Current Assets | $235.96M | $559.61M | $219.51M | $483.16M | $402.60M |
Total Current Assets | $9.30B | $8.98B | $11.20B | $13.95B | $3.87B |
Property Plant Equipment Net | $74.90M | $129.92M | $162.88M | $319.41M | $166.24M |
Goodwill | $59.58M | $66.51M | $2.83M | $- | $- |
Intangible Assets | $52.80M | $69.78M | $4.72M | $8.37M | $5.39M |
Goodwill and Intangible Assets | $112.38M | $136.28M | $7.55M | $8.37M | $5.39M |
Long Term Investments | $7.33B | $7.00B | $4.93B | $2.02B | $4.00M |
Tax Assets | $- | $58.26M | $63.89M | $20.86M | $6.00M |
Other Non-Current Assets | $47.98M | $4.87M | $13.46M | $48.96M | $11.35M |
Total Non-Current Assets | $7.57B | $7.33B | $5.18B | $2.41B | $192.99M |
Other Assets | $- | $- | $- | $- | $- |
Total Assets | $16.87B | $16.32B | $16.38B | $16.37B | $4.06B |
Account Payables | $458.54M | $109.41M | $52.49M | $506.09M | $535.78M |
Short Term Debt | $51.45M | $29.43M | $45.95M | $80.58M | $45.07M |
Tax Payables | $- | $77.16M | $109.68M | $597.76M | $363.64M |
Deferred Revenue | $- | $49.59M | $75.23M | $286.65M | $320.43M |
Other Current Liabilities | $347.87M | $403.08M | $506.48M | $1.27B | $1.23B |
Total Current Liabilities | $857.85M | $668.67M | $789.83M | $2.74B | $2.50B |
Long Term Debt | $7.05M | $24.42M | $39.97M | $104.23M | $98.90M |
Deferred Revenue Non-Current | $- | $- | $-8.65M | $-4.51M | $-5.21M |
Deferred Tax Liabilities Non-Current | $- | $- | $8.65M | $4.51M | $5.21M |
Other Non-Current Liabilities | $16.20M | $23.59M | $- | $- | $-49.45M |
Total Non-Current Liabilities | $23.25M | $48.01M | $48.62M | $108.75M | $54.66M |
Other Liabilities | $- | $- | $- | $- | $- |
Total Liabilities | $881.10M | $716.68M | $838.45M | $2.85B | $2.55B |
Preferred Stock | $- | $- | $- | $- | $- |
Common Stock | $15.99B | $104.00K | $104.00K | $103.00K | $94.00K |
Retained Earnings | $- | $3.77B | $3.32B | $1.91B | $-81.64M |
Accumulated Other Comprehensive Income Loss | $- | $981.30M | $809.95M | $-147.55M | $322.00K |
Other Total Stockholders Equity | $- | $10.86B | $14.76B | $11.75B | $1.59B |
Total Stockholders Equity | $15.99B | $15.61B | $15.57B | $13.51B | $1.51B |
Total Equity | $15.99B | $15.60B | $15.54B | $13.52B | $1.51B |
Total Liabilities and Stockholders Equity | $16.87B | $16.32B | $16.38B | $16.37B | $4.06B |
Minority Interest | $1.74M | $-10.98M | $-28.69M | $3.80M | $- |
Total Liabilities and Total Equity | $16.87B | $16.32B | $16.38B | $16.37B | $4.06B |
Total Investments | $10.23B | $12.73B | $14.45B | $9.66B | $1.97B |
Total Debt | $58.50M | $53.85M | $85.92M | $184.81M | $94.52M |
Net Debt | $-5.53B | $-2.34B | $-1.18B | $-5.02B | $-1.02B |
Balance Sheet Charts
Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | March 31, 2020 | December 31, 2019 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash and Cash Equivalents | $5.59B | $3.26B | $3.08B | $2.32B | $2.39B | $2.52B | $1.76B | $1.45B | $1.27B | $904.78M | $1.71B | $4.38B | $5.21B | $6.37B | $6.53B | $9.65B | $1.11B | $273.04M | $-463.20M | $135.54M |
Short Term Investments | $2.90B | $4.80B | $5.22B | $5.01B | $5.72B | $5.73B | $7.43B | $7.79B | $9.52B | $13.59B | $9.64B | $6.63B | $7.64B | $5.64B | $5.85B | $2.90B | $1.97B | $2.87B | $926.39M | $327.65M |
Cash and Short Term Investments | $8.49B | $8.06B | $8.30B | $7.33B | $8.11B | $8.25B | $9.19B | $9.24B | $10.79B | $14.50B | $11.34B | $11.01B | $12.85B | $12.01B | $12.37B | $12.55B | $3.08B | $3.14B | $463.20M | $463.20M |
Net Receivables | $83.21M | $376.06M | $316.84M | $120.95M | $164.70M | $243.93M | $130.71M | $77.67M | $59.49M | $101.11M | $28.81M | $88.92M | $25.97M | $30.29M | $30.53M | $39.34M | $54.56M | $114.14M | $- | $85.99M |
Inventory | $142.55M | $81.43M | $84.31M | $99.77M | $144.85M | $78.32M | $90.18M | $101.98M | $130.90M | $55.19M | $133.54M | $266.50M | $589.09M | $622.99M | $649.71M | $197.47M | $329.12M | $138.42M | $- | $219.31M |
Other Current Assets | $582.09M | $357.67M | $771.90M | $852.90M | $559.61M | $541.84M | $413.09M | $322.77M | $219.51M | $148.86M | $217.30M | $263.75M | $483.16M | $372.70M | $317.12M | $129.11M | $402.60M | $336.75M | $- | $414.37M |
Total Current Assets | $9.30B | $8.87B | $9.47B | $8.41B | $8.98B | $9.11B | $9.83B | $9.74B | $11.20B | $14.80B | $11.72B | $11.63B | $13.95B | $13.04B | $13.37B | $12.91B | $3.87B | $3.73B | $463.20M | $1.18B |
Property Plant Equipment Net | $74.90M | $88.30M | $102.80M | $117.68M | $129.92M | $125.71M | $158.47M | $151.06M | $162.88M | $182.38M | $246.78M | $322.90M | $319.41M | $339.37M | $222.60M | $178.24M | $166.24M | $164.89M | $- | $176.45M |
Goodwill | $59.58M | $64.53M | $62.61M | $64.14M | $66.51M | $- | $- | $- | $2.83M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Intangible Assets | $52.80M | $59.16M | $60.22M | $65.00M | $69.78M | $5.99M | $6.98M | $7.64M | $4.72M | $8.16M | $8.18M | $10.41M | $8.37M | $8.53M | $6.82M | $4.86M | $5.39M | $5.32M | $- | $5.40M |
Goodwill and Intangible Assets | $112.38M | $123.68M | $122.82M | $129.14M | $136.28M | $5.99M | $6.98M | $7.64M | $7.55M | $8.16M | $8.18M | $10.41M | $8.37M | $8.53M | $6.82M | $4.86M | $5.39M | $5.32M | $- | $5.40M |
Long Term Investments | $7.33B | $7.25B | $6.58B | $7.30B | $7.00B | $7.27B | $6.59B | $6.13B | $4.93B | $1.91B | $5.49B | $3.95B | $2.02B | $2.72B | $2.52B | $1.90B | $4.00M | $5.00M | $- | $5.00M |
Tax Assets | $- | $58.26M | $58.26M | $58.26M | $58.26M | $63.89M | $63.89M | $63.89M | $63.89M | $20.86M | $20.86M | $20.86M | $20.86M | $815.00K | $815.00K | $817.00K | $6.00M | $3.00M | $- | $104.00K |
Other Non-Current Assets | $47.98M | $5.63M | $6.50M | $11.75M | $4.87M | $6.05M | $8.03M | $9.48M | $13.46M | $16.83M | $22.23M | $41.60M | $48.96M | $38.07M | $25.10M | $25.69M | $11.35M | $72.79M | $-463.20M | $74.28M |
Total Non-Current Assets | $7.57B | $7.53B | $6.87B | $7.62B | $7.33B | $7.47B | $6.82B | $6.36B | $5.18B | $2.14B | $5.79B | $4.34B | $2.41B | $3.11B | $2.77B | $2.11B | $192.99M | $251.01M | $-463.20M | $261.24M |
Other Assets | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Total Assets | $16.87B | $16.40B | $16.34B | $16.03B | $16.32B | $16.58B | $16.65B | $16.11B | $16.38B | $16.94B | $17.52B | $15.98B | $16.37B | $16.14B | $16.14B | $15.03B | $4.06B | $3.98B | $- | $1.44B |
Account Payables | $458.54M | $352.40M | $323.81M | $213.85M | $109.41M | $240.00M | $132.19M | $47.35M | $52.49M | $666.25M | $1.39B | $1.00B | $506.09M | $1.45B | $2.18B | $1.56B | $535.78M | $375.65M | $- | $150.48M |
Short Term Debt | $51.45M | $16.71M | $28.20M | $31.09M | $29.43M | $35.70M | $49.29M | $39.33M | $45.95M | $161.03M | $156.94M | $183.96M | $80.58M | $79.84M | $54.75M | $51.40M | $45.07M | $-1.95B | $- | $-118.49M |
Tax Payables | $- | $127.53M | $79.20M | $106.66M | $77.16M | $82.46M | $82.29M | $54.57M | $109.68M | $149.65M | $420.58M | $432.40M | $597.76M | $480.65M | $357.49M | $499.56M | $363.64M | $180.73M | $- | $2.78M |
Deferred Revenue | $- | $24.51M | $56.91M | $15.06M | $49.59M | $68.25M | $94.53M | $45.70M | $75.23M | $33.82M | $459.05M | $216.67M | $286.65M | $115.96M | $118.09M | $90.43M | $320.43M | $146.78M | $- | $18.41M |
Other Current Liabilities | $347.87M | $193.20M | $170.47M | $232.57M | $403.08M | $186.80M | $214.11M | $297.07M | $506.48M | $364.89M | $394.45M | $503.83M | $1.27B | $600.65M | $585.61M | $437.96M | $1.23B | $2.05B | $- | $416.79M |
Total Current Liabilities | $857.85M | $714.35M | $658.59M | $599.22M | $668.67M | $613.22M | $572.41M | $484.02M | $789.83M | $1.38B | $2.82B | $2.34B | $2.74B | $2.73B | $3.29B | $2.64B | $2.50B | $2.80B | $- | $619.90M |
Long Term Debt | $7.05M | $7.14M | $13.12M | $17.97M | $24.42M | $29.61M | $38.88M | $32.06M | $39.97M | $38.06M | $87.85M | $90.95M | $104.23M | $121.28M | $49.82M | $49.70M | $98.90M | $40.87M | $- | $61.34M |
Deferred Revenue Non-Current | $- | $- | $- | $-22.58M | $-23.59M | $-8.65M | $-8.65M | $-8.65M | $-8.65M | $-4.51M | $-4.51M | $-4.51M | $-4.51M | $-5.21M | $-5.21M | $-5.21M | $-5.21M | $- | $- | $- |
Deferred Tax Liabilities Non-Current | $- | $21.76M | $21.79M | $22.58M | $23.59M | $8.65M | $8.65M | $8.65M | $8.65M | $4.51M | $4.51M | $4.51M | $4.51M | $5.21M | $5.21M | $5.21M | $5.21M | $820.00K | $- | $10.57M |
Other Non-Current Liabilities | $16.20M | $- | $- | $- | $- | $- | $- | $8.65M | $- | $- | $- | $- | $- | $- | $- | $- | $-49.45M | $51.78M | $- | $656.59M |
Total Non-Current Liabilities | $23.25M | $28.89M | $34.91M | $40.55M | $48.01M | $38.27M | $47.53M | $40.71M | $48.62M | $42.57M | $92.36M | $95.46M | $108.75M | $126.49M | $55.03M | $54.91M | $54.66M | $93.47M | $- | $717.92M |
Other Liabilities | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Total Liabilities | $881.10M | $743.24M | $693.50M | $639.78M | $716.68M | $651.48M | $619.94M | $524.73M | $838.45M | $1.42B | $2.91B | $2.44B | $2.85B | $2.85B | $3.35B | $2.70B | $2.55B | $2.89B | $- | $1.34B |
Preferred Stock | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Common Stock | $15.99B | $- | $- | $15.40B | $104.00K | $15.94B | $16.06B | $15.61B | $104.00K | $15.56B | $14.64B | $13.55B | $103.00K | $103.00K | $103.00K | $103.00K | $94.00K | $94.00K | $- | $94.00K |
Retained Earnings | $- | $- | $- | $- | $3.77B | $- | $- | $- | $3.32B | $- | $- | $- | $1.91B | $1.45B | $475.63M | $-348.67M | $-81.64M | $141.79M | $- | $46.46M |
Accumulated Other Comprehensive Income Loss | $- | $- | $- | $- | $1.01B | $- | $- | $- | $809.95M | $- | $- | $- | $-147.55M | $32.98M | $-8.93M | $175.84M | $322.00K | $337.00K | $106.28M | $181.00K |
Other Total Stockholders Equity | $- | $15.66B | $15.65B | $- | $10.83B | $- | $- | $- | $14.76B | $- | $- | $- | $11.75B | $11.81B | $12.33B | $12.50B | $1.59B | $946.76M | $- | $59.54M |
Total Stockholders Equity | $15.99B | $15.66B | $15.65B | $15.40B | $15.61B | $15.94B | $16.06B | $15.61B | $15.57B | $15.56B | $14.64B | $13.55B | $13.51B | $13.29B | $12.80B | $12.33B | $1.51B | $1.09B | $106.28M | $106.28M |
Total Equity | $15.99B | $15.66B | $15.65B | $15.39B | $15.60B | $15.93B | $16.03B | $15.58B | $15.54B | $15.53B | $14.61B | $13.54B | $13.52B | $13.29B | $12.80B | $12.33B | $1.51B | $1.09B | $106.28M | $106.28M |
Total Liabilities and Stockholders Equity | $16.87B | $16.40B | $16.34B | $16.03B | $16.32B | $16.58B | $16.65B | $16.11B | $16.38B | $16.94B | $17.52B | $15.98B | $16.37B | $16.14B | $16.14B | $15.03B | $4.06B | $3.98B | $106.28M | $1.44B |
Minority Interest | $1.74M | $-3.70M | $-7.43M | $-10.05M | $-10.98M | $-14.35M | $-26.10M | $-28.03M | $-28.69M | $-32.04M | $-33.92M | $-14.43M | $3.80M | $2.91M | $- | $- | $- | $- | $- | $- |
Total Liabilities and Total Equity | $16.87B | $16.40B | $16.34B | $16.03B | $16.32B | $16.58B | $16.65B | $16.11B | $16.38B | $16.94B | $17.52B | $15.98B | $16.37B | $16.14B | $16.14B | $15.03B | $4.06B | $3.98B | $106.28M | $1.44B |
Total Investments | $10.23B | $12.06B | $11.80B | $12.31B | $12.73B | $12.99B | $14.02B | $13.92B | $14.45B | $15.51B | $15.13B | $10.58B | $9.66B | $8.36B | $8.37B | $4.80B | $1.97B | $2.87B | $926.39M | $332.65M |
Total Debt | $58.50M | $23.85M | $41.33M | $49.06M | $53.85M | $65.31M | $88.16M | $71.39M | $85.92M | $199.08M | $244.79M | $274.91M | $184.81M | $201.12M | $104.58M | $101.10M | $94.52M | $82.55M | $- | $92.78M |
Net Debt | $-5.53B | $-3.23B | $-3.04B | $-2.27B | $-2.34B | $-2.46B | $-1.67B | $-1.38B | $-1.18B | $-705.69M | $-1.46B | $-4.11B | $-5.02B | $-6.17B | $-6.42B | $-9.55B | $-1.02B | $-190.49M | $463.20M | $-42.77M |
Annual Cash Flow
Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
---|---|---|---|---|---|
Net Income | $551.84M | $540.99M | $1.41B | $2.03B | $-128.10M |
Depreciation and Amortization | $- | $96.60M | $159.09M | $113.55M | $62.45M |
Deferred Income Tax | $- | $4.50M | $-38.90M | $-15.55M | $-11.26M |
Stock Based Compensation | $369.65M | $362.87M | $166.16M | $223.34M | $929.10M |
Change in Working Capital | $- | $-307.86M | $-839.80M | $-628.18M | $1.76B |
Accounts Receivables | $- | $23.08M | $-30.41M | $-3.22M | $27.39M |
Inventory | $- | $-39.05M | $179.69M | $-349.04M | $-109.81M |
Accounts Payables | $- | $-30.06M | $-1.02B | $-170.94M | $960.76M |
Other Working Capital | $- | $-261.84M | $30.41M | $-104.99M | $877.62M |
Other Non Cash Items | $-67.14M | $-498.38M | $-368.45M | $78.61M | $-18.76M |
Net Cash Provided by Operating Activities | $854.35M | $198.70M | $486.83M | $1.80B | $2.59B |
Investments in Property Plant and Equipment | $- | $-28.22M | $-38.64M | $-138.84M | $-17.45M |
Acquisitions Net | $- | $-2.09B | $- | $7.90M | $-4.87M |
Purchases of Investments | $- | $-17.13B | $-45.79B | $-21.72B | $-7.47B |
Sales Maturities of Investments | $- | $19.25B | $16.12B | $13.99B | $5.74B |
Other Investing Activities | $3.02B | $2.09B | $25.58B | $-7.90M | $-65.83M |
Net Cash Used for Investing Activities | $3.02B | $2.09B | $-4.13B | $-7.87B | $-1.81B |
Debt Repayment | $- | $- | $-1.40M | $- | $- |
Common Stock Issued | $- | $- | $- | $10.04B | $- |
Common Stock Repurchased | $- | $-996.63M | $-500.37M | $-127.52M | $- |
Dividends Paid | $- | $-92.38M | $-640.00K | $-325.45M | $- |
Other Financing Activities | $-678.03M | $-104.20M | $24.50M | $314.66M | $174.88M |
Net Cash Used Provided by Financing Activities | $-678.03M | $-1.19B | $-477.27M | $9.90B | $174.88M |
Effect of Forex Changes on Cash | $29.98M | $34.34M | $203.10M | $-78.69M | $19.34M |
Net Change in Cash | $3.22B | $1.13B | $-3.92B | $3.75B | $970.71M |
Cash at End of Period | $5.64B | $2.42B | $1.29B | $5.21B | $1.45B |
Cash at Beginning of Period | $2.42B | $1.29B | $5.21B | $1.45B | $484.09M |
Operating Cash Flow | $854.35M | $198.70M | $486.83M | $1.80B | $2.59B |
Capital Expenditure | $- | $-32.41M | $-38.64M | $-138.84M | $-17.45M |
Free Cash Flow | $854.35M | $166.29M | $448.19M | $1.66B | $2.57B |
Cash Flow Charts
Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | $121.96M | $- | $- | $131.91M | $213.48M | $170.99M | $202.79M | $-56.30M | $703.45M | $503.36M | $461.06M | $705.28M | $493.52M | $973.91M | $824.30M | $-267.03M | $-236.75M | $7.83M | $88.71M | $12.10M |
Depreciation and Amortization | $- | $- | $- | $- | $96.60M | $- | $- | $- | $159.09M | $- | $- | $- | $108.77M | $- | $- | $- | $14.66M | $- | $- | $- |
Deferred Income Tax | $- | $- | $- | $- | $- | $- | $- | $- | $-38.90M | $- | $- | $- | $-15.55M | $- | $- | $- | $1.39M | $- | $- | $- |
Stock Based Compensation | $124.12M | $- | $- | $74.90M | $216.62M | $24.79M | $-118.49M | $239.95M | $474.85M | $-176.63M | $193.18M | $-325.24M | $223.34M | $-523.74M | $-172.54M | $877.51M | $656.09M | $238.17M | $21.04M | $13.80M |
Change in Working Capital | $- | $- | $- | $- | $-215.15M | $- | $- | $- | $-839.80M | $- | $- | $- | $-316.56M | $- | $- | $- | $861.02M | $- | $- | $- |
Accounts Receivables | $- | $- | $- | $- | $23.08M | $- | $- | $- | $-30.41M | $- | $- | $- | $-3.22M | $- | $- | $- | $19.52M | $- | $- | $- |
Inventory | $- | $- | $- | $- | $-39.05M | $- | $- | $- | $179.69M | $- | $- | $- | $-349.04M | $- | $- | $- | $-190.70M | $- | $- | $- |
Accounts Payables | $- | $- | $- | $- | $- | $- | $- | $- | $-1.02B | $- | $- | $- | $-170.94M | $- | $- | $- | $571.85M | $- | $- | $- |
Other Working Capital | $- | $- | $- | $- | $-199.18M | $- | $- | $- | $30.41M | $- | $- | $- | $203.41M | $- | $- | $- | $460.35M | $- | $- | $- |
Other Non Cash Items | $250.93M | $156.55M | $196.76M | $-202.79M | $-109.50M | $-128.33M | $-314.98M | $-414.33M | $-398.87M | $-1.34B | $790.15M | $-397.11M | $-27.79M | $-1.12B | $-174.86M | $1.09B | $-6.30M | $-7.83M | $481.81M | $-82.19M |
Net Cash Provided by Operating Activities | $497.01M | $156.55M | $196.76M | $4.02M | $320.60M | $67.45M | $-230.69M | $-230.69M | $-248.87M | $-1.02B | $1.44B | $308.17M | $465.74M | $-142.85M | $649.44M | $827.57M | $1.29B | $798.83M | $570.52M | $-70.09M |
Investments in Property Plant and Equipment | $- | $- | $- | $- | $-28.22M | $- | $- | $- | $-38.64M | $- | $- | $- | $-130.94M | $- | $- | $- | $-4.22M | $- | $- | $- |
Acquisitions Net | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $9.66B | $- | $- | $- | $-953.00K | $- | $- | $- |
Purchases of Investments | $- | $- | $- | $- | $- | $- | $- | $- | $-45.79B | $- | $- | $- | $-21.72B | $- | $- | $- | $-2.35B | $- | $- | $- |
Sales Maturities of Investments | $- | $- | $- | $- | $- | $- | $- | $- | $16.12B | $- | $- | $- | $12.19B | $- | $- | $- | $3.21B | $- | $- | $- |
Other Investing Activities | $1.90B | $139.12M | $557.13M | $420.67M | $310.17M | $967.34M | $381.95M | $381.95M | $30.46B | $211.06M | $-4.15B | $-950.76M | $-1.40B | $-38.53M | $-3.62B | $-2.81B | $-16.36M | $-746.21M | $-829.09M | $-1.07B |
Net Cash Used for Investing Activities | $1.90B | $139.12M | $557.13M | $420.67M | $310.17M | $967.34M | $381.95M | $381.95M | $752.54M | $211.06M | $-4.15B | $-950.76M | $-1.40B | $-38.53M | $-3.62B | $-2.81B | $829.50M | $-746.21M | $-829.09M | $-1.07B |
Debt Repayment | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Common Stock Issued | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Common Stock Repurchased | $- | $- | $- | $- | $-996.63M | $- | $- | $- | $-500.37M | $- | $- | $- | $-127.52M | $- | $- | $- | $- | $- | $- | $- |
Dividends Paid | $- | $- | $- | $- | $-92.38M | $- | $- | $- | $-640.00K | $- | $- | $- | $-325.45M | $- | $- | $- | $- | $- | $- | $- |
Other Financing Activities | $-130.37M | $-74.78M | $- | $-472.88M | $-768.99M | $-229.49M | $-199.08M | $4.35M | $-150.01M | $-19.82M | $-145.19M | $-161.61M | $197.93M | $389.00K | $-6.17M | $10.04B | $-1.20B | $324.27M | $234.95M | $816.32M |
Net Cash Used Provided by Financing Activities | $-130.37M | $-74.78M | $- | $-472.88M | $-768.99M | $-229.49M | $4.35M | $4.35M | $-150.65M | $-19.82M | $-145.19M | $-161.61M | $-127.52M | $389.00K | $-6.17M | $10.04B | $-1.20B | $324.27M | $234.95M | $816.32M |
Effect of Forex Changes on Cash | $62.87M | $-45.82M | $10.03M | $2.90M | $-18.90M | $-5.56M | $10.41M | $10.41M | $29.29M | $22.77M | $171.60M | $-20.56M | $-99.77M | $23.37M | $-146.51M | $144.23M | $-10.67M | $15.91M | $6.42M | $7.67M |
Net Change in Cash | $2.33B | $175.08M | $763.93M | $-45.30M | $-157.13M | $799.74M | $166.02M | $166.02M | $382.32M | $-802.85M | $-2.68B | $-824.76M | $-1.16B | $-157.62M | $-3.12B | $8.19B | $908.30M | $392.81M | $-17.19M | $-313.21M |
Cash at End of Period | $5.64B | $3.31B | $3.14B | $2.37B | $2.42B | $2.58B | $1.46B | $1.46B | $1.29B | $906.77M | $1.71B | $4.38B | $5.21B | $6.37B | $6.53B | $9.65B | $1.45B | $546.50M | $153.69M | $170.88M |
Cash at Beginning of Period | $3.31B | $3.14B | $2.37B | $2.42B | $2.58B | $1.78B | $1.29B | $1.29B | $906.77M | $1.71B | $4.38B | $5.21B | $6.37B | $6.53B | $9.65B | $1.45B | $546.50M | $153.69M | $170.88M | $484.09M |
Operating Cash Flow | $497.01M | $156.55M | $196.76M | $4.02M | $320.60M | $67.45M | $-230.69M | $-230.69M | $-248.87M | $-1.02B | $1.44B | $308.17M | $465.74M | $-142.85M | $649.44M | $827.57M | $1.29B | $798.83M | $570.52M | $-70.09M |
Capital Expenditure | $- | $- | $- | $- | $-28.22M | $- | $- | $- | $-38.64M | $- | $- | $- | $-130.94M | $- | $- | $- | $-4.22M | $- | $- | $- |
Free Cash Flow | $497.01M | $156.55M | $196.76M | $4.02M | $292.38M | $67.45M | $-230.69M | $-230.69M | $-287.50M | $-1.02B | $1.44B | $308.17M | $334.80M | $-142.85M | $649.44M | $827.57M | $1.29B | $798.83M | $570.52M | $-70.09M |
RLX Technology Dividends
Explore RLX Technology's dividend history, including dividend yield, payout ratio, and historical payments.
Dividend Yield
-
Dividend Payout Ratio
-
Dividend Paid & Capex Coverage Ratio
0.00x
RLX Technology Dividend History
Dividend | Adjusted Dividend | Date | Record Date | Payment Date | Declaration Date |
---|---|---|---|---|---|
$0.008 | $0.008 | December 06, 2024 | December 06, 2024 | December 20, 2024 | November 15, 2024 |
$0.008 | $0.008 | November 30, 2023 | December 01, 2023 | December 22, 2023 | November 13, 2023 |
RLX Technology News
Read the latest news about RLX Technology, including recent articles, headlines, and updates.
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against RLX Technology Inc. (RLX) And Encourages Shareholders to Reach Out
NEW YORK, NY / ACCESS Newswire / April 2, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of RLX Technology Inc. ("RLX" or "the Company") (NYSE:RLX). Investors who purchased RLX securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/RLX.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RLX Technology Inc. - RLX
NEW YORK CITY, NY / ACCESS Newswire / April 1, 2025 / Pomerantz LLP is investigating claims on behalf of investors of RLX Technology Inc. ("RLX" or the "Company") (NYSE:RLX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against RLX Technology Inc. (RLX) and Encourages Shareholders to Learn More About the Investigation
NEW YORK, NY / ACCESS Newswire / April 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of RLX Technology Inc. ("RLX" or "the Company") (NYSE:RLX). Investors who purchased RLX securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/RLX.

RLX Technology Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights - RLX
NEW YORK, NY / ACCESS Newswire / March 31, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of RLX Technology Inc. ("RLX Technology Inc.") (NYSE:RLX) concerning possible violations of federal securities laws. Citi downgraded RLX stock to Neutral from Buy on March 17, 2025, citing overseas headwinds from regulatory changes and an unfavorable product mix shift, and predicting that organic growth of RLX's overseas business will decelerate in 2025.

Shareholder Rights Advocates at Levi & Korsinsky Investigate RLX Technology Inc. (RLX) Regarding Possible Securities Fraud Violations
NEW YORK, NY / ACCESS Newswire / March 31, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of RLX Technology Inc. ("RLX Technology Inc.") (NYSE:RLX) concerning possible violations of federal securities laws. Citi downgraded RLX stock to Neutral from Buy on March 17, 2025, citing overseas headwinds from regulatory changes and an unfavorable product mix shift, and predicting that organic growth of RLX's overseas business will decelerate in 2025.

RLX Technology Inc. (RLX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation
NEW YORK, NY / ACCESS Newswire / March 31, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of RLX Technology Inc. ("RLX" or "the Company") (NYSE:RLX). Investors who purchased RLX securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/RLX.

Levi & Korsinsky Announces an Investigation on Behalf of RLX Technology Inc. (RLX) Shareholders Who May Have Been Affected by Fraud
NEW YORK, NY / ACCESS Newswire / March 30, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of RLX Technology Inc. ("RLX Technology Inc.") (NYSE:RLX) concerning possible violations of federal securities laws. Citi downgraded RLX stock to Neutral from Buy on March 17, 2025, citing overseas headwinds from regulatory changes and an unfavorable product mix shift, and predicting that organic growth of RLX's overseas business will decelerate in 2025.

RLX Technology Inc. (RLX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation
NEW YORK, NY / ACCESS Newswire / March 30, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of RLX Technology Inc. ("RLX" or "the Company") (NYSE:RLX). Investors who purchased RLX securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/RLX.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RLX Technology Inc. - RLX
NEW YORK, March 30, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of RLX Technology Inc. (“RLX” or the “Company”) (NYSE: RLX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.

RLX ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your RLX Technology Inc. investment
NEW YORK, NY / ACCESS Newswire / March 28, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of RLX Technology Inc. ("RLX Technology Inc.") (NYSE:RLX) concerning possible violations of federal securities laws. Citi downgraded RLX stock to Neutral from Buy on March 17, 2025, citing overseas headwinds from regulatory changes and an unfavorable product mix shift, and predicting that organic growth of RLX's overseas business will decelerate in 2025.

Bronstein, Gewirtz & Grossman, LLC Is Investigating RLX Technology Inc. (RLX) And Encourages Investors to Connect
NEW YORK, NY / ACCESS Newswire / March 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of RLX Technology Inc. ("RLX" or "the Company") (NYSE:RLX). Investors who purchased RLX securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/RLX.

An Investigation Has Commenced on Behalf of RLX Technology Inc. Shareholders. Contact Levi & Korsinsky to Discuss your RLX Losses.
NEW YORK, NY / ACCESS Newswire / March 27, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of RLX Technology Inc. ("RLX Technology Inc.") (NYSE:RLX) concerning possible violations of federal securities laws. Citi downgraded RLX stock to Neutral from Buy on March 17, 2025, citing overseas headwinds from regulatory changes and an unfavorable product mix shift, and predicting that organic growth of RLX's overseas business will decelerate in 2025.

Levi & Korsinsky Reminds RLX Technology Inc. Investors of the Ongoing Investigation into Potential Violations of Securities Laws - RLX
NEW YORK, NY / ACCESS Newswire / March 26, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of RLX Technology Inc. ("RLX Technology Inc.") (NYSE:RLX) concerning possible violations of federal securities laws. Citi downgraded RLX stock to Neutral from Buy on March 17, 2025, citing overseas headwinds from regulatory changes and an unfavorable product mix shift, and predicting that organic growth of RLX's overseas business will decelerate in 2025.

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against RLX Technology Inc. (RLX) and Encourages Investors to Learn More About the Investigation
NEW YORK, NY / ACCESS Newswire / March 26, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of RLX Technology Inc. ("RLX" or "the Company") (NYSE:RLX). Investors who purchased RLX securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/RLX.

Levi & Korsinsky Investigates Possible Securities Fraud Violations by RLX Technology Inc. (RLX)
NEW YORK, NY / ACCESS Newswire / March 25, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of RLX Technology Inc. ("RLX Technology Inc.") (NYSE:RLX) concerning possible violations of federal securities laws. Citi downgraded RLX stock to Neutral from Buy on March 17, 2025, citing overseas headwinds from regulatory changes and an unfavorable product mix shift, and predicting that organic growth of RLX's overseas business will decelerate in 2025.

RLX ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of RLX Technology Inc. Shareholders Who Lost Money
NEW YORK, NY / ACCESS Newswire / March 24, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of RLX Technology Inc. ("RLX Technology Inc.") (NYSE:RLX) concerning possible violations of federal securities laws. Citi downgraded RLX stock to Neutral from Buy on March 17, 2025, citing overseas headwinds from regulatory changes and an unfavorable product mix shift, and predicting that organic growth of RLX's overseas business will decelerate in 2025.

RLX ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by RLX Technology Inc.
NEW YORK, NY / ACCESS Newswire / March 24, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of RLX Technology Inc. ("RLX Technology Inc.") (NYSE:RLX) concerning possible violations of federal securities laws. Citi downgraded RLX stock to Neutral from Buy on March 17, 2025, citing overseas headwinds from regulatory changes and an unfavorable product mix shift, and predicting that organic growth of RLX's overseas business will decelerate in 2025.

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against RLX Technology Inc. (RLX) And Encourages Stockholders to Reach Out
NEW YORK, NY / ACCESS Newswire / March 24, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of RLX Technology Inc. ("RLX" or "the Company") (NYSE:RLX). Investors who purchased RLX securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/RLX.

Bronstein, Gewirtz & Grossman, LLC Is Investigating RLX Technology Inc. (RLX) And Encourages Stockholders to Connect
NEW YORK, NY / ACCESS Newswire / March 23, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of RLX Technology Inc. ("RLX" or "the Company") (NYSE:RLX). Investors who purchased RLX securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/RLX.

Similar Companies
Related Metrics
Explore detailed financial metrics and analysis for RLX.